Hiroshi Obayashi Selected Research

Hiroshi Obayashi Research Topics

Disease

14	Type 2 Diabetes Mellitus (MODY) 01/2011 - 09/2002
9	Insulin Resistance 03/2012 - 01/2004
9	Endometriosis 12/2007 - 01/2002
5	Genetic Predisposition to Disease (Genetic Predisposition) 12/2007 - 01/2002
3	Glucose Intolerance 03/2012 - 03/2008
3	Non-alcoholic Fatty Liver Disease 01/2011 - 04/2010
2	Fibrosis (Cirrhosis) 01/2018 - 03/2011
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2015 - 09/2002
2	Fatty Liver 01/2013 - 01/2011
2	Rheumatoid Arthritis 03/2011 - 03/2007
2	Hyperglycemia 01/2010 - 03/2009
2	Diabetic Retinopathy (Retinopathy, Diabetic) 09/2007 - 08/2003
1	Acute Lung Injury 02/2016
1	Colitis 02/2016
1	Infections 12/2009
1	Stomach Neoplasms (Stomach Cancer) 12/2009
1	Ischemia 10/2008
1	Hypoxia (Hypoxemia) 10/2008
1	Stomach Diseases 07/2008
1	Atopic Dermatitis (Atopic Eczema) 02/2007
1	Autoimmune Diseases (Autoimmune Disease) 02/2007
1	Hypertension (High Blood Pressure) 12/2006
1	Uterine Diseases (Endometrial Disease) 07/2006
1	Adenomyosis 07/2006
1	Atherosclerosis 01/2006
1	Obesity 01/2004
1	Vitreous Hemorrhage 08/2003

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2015 - 01/2005
4	Lipoproteins (Lipoprotein)IBA 01/2013 - 04/2008
4	Glucose (Dextrose)FDA LinkGeneric 03/2012 - 03/2008
4	Interleukin-6 (Interleukin 6)IBA 03/2011 - 08/2003
4	CytokinesIBA 12/2009 - 08/2004
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2013 - 11/2010
3	oxidized low density lipoproteinIBA 01/2013 - 01/2010
3	Insulin (Novolin)FDA Link 03/2012 - 07/2005
3	nasIBA 01/2011 - 04/2010
3	LipidsIBA 01/2011 - 03/2008
3	Biomarkers (Surrogate Marker)IBA 07/2008 - 12/2006
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2007 - 05/2004
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2018 - 02/2016
2	gluconolactonaseIBA 01/2015 - 03/2012
2	Messenger RNA (mRNA)IBA 01/2013 - 07/2008
2	Ezetimibe (Zetia)FDA Link 01/2011 - 11/2010
2	LDL Lipoproteins (beta Lipoproteins)IBA 04/2010 - 04/2008
2	AdiponectinIBA 01/2010 - 12/2006
2	HLA Antigens (Human Leukocyte Antigens)IBA 12/2009 - 02/2003
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 07/2008 - 02/2007
2	Retinaldehyde (Retinal)IBA 09/2007 - 08/2003
2	pentosidineIBA 09/2007 - 08/2003
2	Advanced Glycation End ProductsIBA 09/2007 - 08/2003
2	ResistinIBA 01/2006 - 01/2004
2	AntibodiesIBA 07/2005 - 01/2004
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 05/2004 - 02/2003
2	ImmunosorbentsIBA 01/2004 - 04/2003
2	EnzymesIBA 01/2004 - 04/2003
1	indium-bleomycinIBA 01/2018
1	Sulfonic AcidsIBA 02/2016
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 03/2012
1	CholesterolIBA 01/2011
1	LDL CholesterolIBA 01/2011
1	Triglycerides (Triacylglycerol)IBA 01/2011
1	CarbohydratesIBA 01/2011
1	Pharmaceutical PreparationsIBA 01/2011
1	palmitoleic acidIBA 11/2010
1	Cholesterol Esters (Cholesteryl Esters)IBA 11/2010
1	PalmitatesIBA 11/2010
1	Collagen Type IV (Type IV Collagen)IBA 04/2010
1	Pioglitazone (Actos)FDA Link 01/2010
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2010
1	Metformin (Glucophage)FDA LinkGeneric 01/2010
1	Telmisartan (Micardis)FDA Link 03/2009
1	Superoxides (Superoxide)IBA 10/2008
1	10,10'-dimethyl-9,9'-biacridinium (Lucigenin)IBA 10/2008
1	Hemoglobins (Hemoglobin)IBA 09/2008
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 07/2008
1	Glycoside Hydrolase InhibitorsIBA 04/2008
1	glimepiride (Amarel)FDA LinkGeneric 04/2008
1	Acarbose FDA LinkGeneric 04/2008
1	HydrogenIBA 03/2008
1	KIR ReceptorsIBA 12/2007
1	Angiotensin Receptor AntagonistsIBA 09/2007
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2007
1	Nerve Growth Factor (NGF)IBA 02/2007
1	Nerve Growth Factors (Neurotrophins)IBA 02/2007
1	Losartan (Cozaar)FDA LinkGeneric 12/2006
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 10/2006
1	Estrogens (Estrogen)FDA Link 07/2006
1	PPAR gammaIBA 07/2006
1	Atorvastatin (Lipitor)FDA Link 01/2006
1	Cysteine (L-Cysteine)FDA Link 01/2006
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 07/2005
1	Immunologic Factors (Immunomodulators)IBA 01/2005
1	Interleukin-4 (Interleukin 4)IBA 08/2004
1	Interferon-gamma (Interferon, gamma)IBA 08/2004
1	Type II Tumor Necrosis Factor ReceptorsIBA 05/2004
1	Hormones (Hormone)IBA 01/2004
1	Superoxide DismutaseIBA 04/2003

Therapy/Procedure

2	Glycemic Control 01/2011 - 01/2008
2	Therapeutics 01/2011 - 11/2010
1	Aftercare (After-Treatment) 01/2011